Cancer Research Network

Cancer Research Network
Name	Cancer Research Network
Caption	Collaborative cancer epidemiology and health-services research network
Formation	1998
Type	Research consortium
Headquarters	United States
Membership	Multiple integrated health care systems
Leader title	Director

Cancer Research Network

The Cancer Research Network is a consortium of integrated health care systems and research centers established to conduct collaborative population-based cancer research across multiple United States health plans, aiming to improve prevention, detection, treatment, and survivorship. It brings together investigators from Harvard Medical School, Kaiser Permanente, Fred Hutchinson Cancer Research Center, Mayo Clinic, and other institutions to leverage large-linked databases, electronic health records, and multisite cohorts for comparative effectiveness, epidemiology, and implementation science. The Network supports multicenter studies that inform practice, policy, and clinical guidelines used by organizations such as the National Cancer Institute, Centers for Disease Control and Prevention, and professional societies.

Overview

The consortium operates as a distributed research network connecting investigators at sites including Kaiser Permanente Northern California, Kaiser Permanente Southern California, HealthPartners, Group Health Cooperative, and affiliated academic partners such as University of Washington, Johns Hopkins University School of Medicine, and University of California, San Francisco. It emphasizes multisite study designs, pooled analyses, and use of linked electronic data from sources like tumor registries and administrative claims, collaborating with national resources including the Surveillance, Epidemiology, and End Results Program and cooperative groups such as the Alliance for Clinical Trials in Oncology and SWOG. The Network facilitates investigator-initiated and sponsored projects, training, and cross-site methodological development with ties to federal programs such as the Research Centers in Minority Institutions initiative and the Patient-Centered Outcomes Research Institute.

History and Development

Founded in 1998 with initial funding and conceptual support from the National Cancer Institute, the organization grew from early multicenter efforts involving Group Health Cooperative and regional partners to a formal network including major integrated systems like Kaiser Permanente and academic centers like Mayo Clinic. Key developmental milestones include adoption of common data models influenced by initiatives at Harvard Pilgrim Health Care and methodological collaborations with the Agency for Healthcare Research and Quality. Over time the Network expanded its scope from observational epidemiology to include comparative effectiveness studies, pragmatic trials, and implementation science aligned with federal priorities such as the Cancer Moonshot and national cancer control strategies promoted by the Institute of Medicine.

Organizational Structure and Membership

Governance typically comprises a steering committee of site principal investigators, methodologists, and representatives from participating health plans and academic partners such as University of Minnesota, University of Michigan, and Columbia University. Membership spans integrated systems (for example, Kaiser Foundation Health Plan affiliates), academic research centers (including Fred Hutchinson Cancer Research Center and Dana-Farber Cancer Institute collaborators), and specialty registries like state cancer registries coordinated with the North American Association of Central Cancer Registries. The Network operates working groups for data management, protocols, ethics and human subjects oversight interacting with institutional review boards at institutions like Stanford University and Yale University School of Medicine.

Research Focus and Programs

Primary areas of inquiry include cancer etiology and risk-factor epidemiology, screening and early detection, comparative effectiveness of treatments, survivorship and quality of life, cancer disparities, and implementation of evidence-based interventions. Programs often align with disease-specific consortia focusing on common cancers such as breast cancer, colorectal cancer, lung cancer, and prostate cancer, and on high-impact topics like HPV vaccination in collaboration with organizations such as the American Cancer Society and the Advisory Committee on Immunization Practices. The Network supports pragmatic clinical trials, retrospective cohort studies, and case–control analyses, and contributes to guideline development used by bodies like the U.S. Preventive Services Task Force.

Data Infrastructure and Methods

The Network uses a distributed common data model linking electronic health records, tumor registry data, pharmacy records, and claims to enable pooled analyses while preserving local control of identifiable data. Methodological innovations draw on approaches from multi-site consortia such as the HMO Research Network and use standardized coding systems exemplified by the International Classification of Diseases and registry standards from the North American Association of Central Cancer Registries. Statistical methods include propensity-score techniques, instrumental-variable analyses, and pragmatic trial designs adapted from work at Duke University and University of Pennsylvania. The infrastructure supports rapid-cycle surveillance, comparative effectiveness research tied to Medicare data administrators like Centers for Medicare & Medicaid Services, and data linkages with biorepositories at institutions such as Vanderbilt University Medical Center.

Key Studies and Contributions

The Network has contributed to large observational studies and multisite trials that influenced screening recommendations, treatment patterns, and survivorship care. Notable multisite projects evaluated screening intervals for mammography and colorectal screening modalities, assessed tobacco-cessation and lung-cancer screening interventions alongside initiatives like the National Lung Screening Trial, and examined adjuvant therapy patterns for breast and colorectal cancers. Publications from Network investigators have informed policy decisions at the National Institutes of Health and guideline panels at the American Society of Clinical Oncology and the U.S. Preventive Services Task Force.

Funding and Partnerships

Primary funding has come from the National Cancer Institute alongside grants from the Patient-Centered Outcomes Research Institute, cooperative agreements with state cancer registries, and philanthropic support from organizations such as the American Cancer Society and private foundations. Partnerships extend to federal agencies including the Centers for Disease Control and Prevention and the Centers for Medicare & Medicaid Services, academic centers like Mayo Clinic and Johns Hopkins University, and industry collaborations for pragmatic trial execution. The Network also engages with advocacy organizations such as Susan G. Komen and professional societies including the American Society of Clinical Oncology for dissemination and implementation of findings.

Category:Cancer research organizations